Join a panel discussion hosted by IQVIA Biotech and ASLAN Pharmaceuticals and featuring thought leaders in dermatology, Jonathan Silverberg, MD, PhD, MPH (The George Washington University School of Medicine and Health Sciences) and April W. Armstrong, MD, MPH (UCLA Health).

The panel will discuss changes in the clinical trial and treatment landscape for atopic dermatitis (AD), the impact these changes have on clinical data and new therapies, and potential solutions for optimizing AD trials. New market research data will also be presented highlighting prescriber views of current and future therapies.